- Rhythm Pharmaceuticals ( NASDAQ: RYTM ) is scheduled to announce Q4 earnings results on Wednesday, March 1st, before market open.
- The consensus EPS Estimate is -$0.78 (+8.2% Y/Y) and the consensus Revenue Estimate is $7.16M (+293.4% Y/Y).
- Over the last 1 year, RYTM has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 0 upward revisions and 3 downward.
For further details see:
Rhythm Pharmaceuticals Q4 2022 Earnings Preview